Fatty Liver Treatment BREAKTHROUGH
Brad Stanfield
Oct 25, 2025
Episode description
For weekly health research summaries and extra insights, sign up here 👉 https://drstanfield.com/pages/sign-up
💊 Supplements I Take: https://drstanfield.com/pages/my-supplements
💊MicroVitamin+ (Pro) Powder: https://drstanfield.com/products/microvitamin-plus
💊MicroVitamin Standard Capsules: https://drstanfield.com/products/microvitamin
Timestamps:
00:00 GLP-1 Medications and Fatty Liver Disease
01:42 Fatty Liver Disease and Its Long-Term Damage
02:10 Trials and Effectiveness of GLP-1 Medications
04:05 Importance of Diet in Managing Fatty Liver Disease
05:02 The Role of Exercise in Preserving Muscle Mass
05:37 Additional Factors in Managing Fatty Liver Disease
06:45 Long-Term Use of GLP-1 Therapies and Conclusion
📜 Roadmap - how to look young & feel strong: https://drstanfield.com/pages/roadmap
✔️ Twitter: https://twitter.com/BradStanfieldMD
✔️ Patreon: https://www.patreon.com/bradstanfieldmd
Here are the links to the research papers referenced in the video:
https://diabetesjournals.org/spectrum/article/37/1/9/153831/Understanding-the-Burden-of-Nonalcoholic-Fatty
https://pubmed.ncbi.nlm.nih.gov/26608256/
https://pubmed.ncbi.nlm.nih.gov/38856224/
https://www.nejm.org/doi/full/10.1056/NEJMoa2413258
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-serious-liver-disease-known-mash
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2821080
https://pmc.ncbi.nlm.nih.gov/articles/PMC5161655/
https://pubmed.ncbi.nlm.nih.gov/38629387/
https://www.sciencedirect.com/science/article/pii/S2161831322006810
https://www.ahajournals.org/doi/10.1161/ATV.0000000000000153
https://pmc.ncbi.nlm.nih.gov/articles/PMC8308484/
https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14725
Thumbnail by James Kelly
Video edited by Troy Young
Script by John Milliken
The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.
Mindsip insights from this episode:
Incorporate resistance exercise to halve muscle loss during weight loss
Clinical trial evidence shows that adding resistance exercise during weight loss can reduce the amount of lean muscle you lose by about half.
Resolve fatty liver disease with tirzepatide's highest dose
In a recent trial, the highest dose of tirzepatide resolved fatty liver disease in an incredible 62% of participants without worsening liver scarring.
Maintain GLP1 therapy to prevent rapid weight regain
GLP1 medications are considered long-term treatments because when people stop taking them, the lost weight tends to return very quickly.
Implement aggressive treatment for fatty liver to reduce heart disease risk
Because fatty liver is an independent risk factor for heart disease, it justifies more aggressive treatment to lower LDL cholesterol and APOB.
Address non-alcoholic fatty liver disease prevalence in the USA
About 38% of people in the USA have non-alcoholic fatty liver disease, a figure that has surged by 50% in the last three decades.
Increase protein intake to preserve muscle on GLP1s
To prevent muscle loss on GLP1s, it's advised to increase protein intake to 1.2 grams per kilogram of your ideal body weight, focusing on plant-based sources.
Drink black coffee to reduce liver scarring in fatty liver disease
Research shows that black coffee consumption is inversely related to the severity of liver scarring in people with fatty liver disease.
Leverage newer GLP1s for enhanced weight loss results
Newer GLP1 drugs like tirzepatide cause greater weight loss than semaglutide because they target two metabolic pathways instead of just one.
